Overseas markets have become new drivers of growth, and pharmaceutical equipment companies have high enthusiasm for development

[Pharmaceutical Network Market Analysis] Recently, Chutian Technology, a leading domestic pharmaceutical equipment company, mentioned in an investigation that the company's headquarters plans to double the target of new orders for export business this year compared with 2021, and plans to achieve export business revenue around 2025 about 50% of total reven.
At the same time, it is hoped that ROMACO will achieve sales of 300 million euros by 202In the context of the intensified homogenization competition in the domestic pharmaceutical equipment market, as well as the technological upgrading and product quality improvement of domestic pharmaceutical machinery enterprises, pharmaceutical machinery enterprises including Chutian Technology have accelerated the pace of internationalization, and overseas markets are becoming their growth new driv.
 Pharmaceutical Equipment (Source: Pharmaceutical Network) Overseas Market Becomes a New Growth Driver The reason why Chutian Technology attaches great importance to export business is undoubtedly its broad market prospec.
With the intensification of homogenization competition in the domestic pharmaceutical equipment market, enterprises are caught in a low price war, and the internationalization of layout is expected to bring new growth points to enterpris.
In addition, since 2020, the overseas orders of domestic pharmaceutical machine companies with fast delivery capabilities have grown significantly, and the pace of internationalization is accelerati.
Judging from the annual report, many pharmaceutical machine companies that have deployed overseas markets have already tasted the sweetne.
Among them, the overseas revenue growth rate of Chutian Technology after consolidation with Germany's Romaco Group is obvio.
In 2021, overseas revenue accounts for nearly 35% of the overall revenue, an increase of nearly 15% compared with 219% in 202During the reporting period, the company achieved a total revenue of 26 billion yuan, up 408% from the previous year; net profit reached 566 million yuan, up 1845% year-on-ye.
Tofflon's overseas sales revenue in 2021 will be 04 billion yuan, accounting for about 28% of the overall reven.
The annual report shows that in 2021, Tofflon achieved revenue of 192 billion yuan, a year-on-year increase of 583%, a new high in three years, and achieved a net profit of 828 million yuan attributable to the parent, a year-on-year increase of 75
Canaan Technology’s overseas performance has also achieved rapid grow.
In 2020, its overseas performance increased by more than 80% year-on-ye.
At that time, the company predicted that there are three main areas for the future growth of the industry, one of which is that the high-end market in the international market will usher in more opportunities for product expo.
Guosheng Securities once stated that the overseas demand for domestic vaccine equipment is strong, and at the same time, it has driven conventional vaccine equipment, biopharmaceutical equipment, e.
to enter the supply chain of many pharmaceutical compani.
It is expected that the internationalization process of domestic pharmaceutical equipment will accelera.
Listed companies with high enthusiasm for development From the sales of products to Indonesia in 2002, to the complete acquisition of Germany's Romaco Group in recent years, covering more than 100 countries including Europe and the United States, Chutian Technology's influence in the international market continues to increa.

In May of this year, Chutian Technology announced to speed up its internationalization and globalizati.

In the form of subsidiaries and other companies, it has established branches in India, South Korea, Vietnam, Russia, Uzbekistan, Bangladesh, Thailand, Turkey, Egypt, the United Arab Emirates, Italy, the United States, and Braz.

Sales and Service Centers (SSC) have been set up in 13 countries, which means that Chutian Technology is further moving towards the localized operation in the international market, and responds to and meets the needs of overseas customers in a more timely mann.

According to the vision of Chutian Technology, the third important milestone of its internationalization and globalization is to set up sales and service centers of Chutian Technology in 100 major industrialized countries and economies around the wor.

Today, Chutian Technology is continuing to expand its territory on a global scale, chasing its drea.

Tofflon, which started its internationalization in 2003, started from the Indian market and gradually sold its products to 45 countries and regio.
The company has also been actively expanding overseas markets in recent yea.

Especially since 2020, Tofflon has taken vaccine preparation as an entry point and has quickly opened up markets in developed countries such as Europe, changing the situation in which overseas revenue mainly came from Asia in the pa.

At present, Tofflon has accelerated its internationalization by setting up new subsidiaries in Hong Kong, Indonesia, Turkey, Australia, Dubai, Vietnam, South Africa and other countries or regio.

According to the company's goal, it hopes to increase the proportion of overseas revenue to 50% in the futu.

Guosheng Securities believes that domestic pharmaceutical equipment companies are accelerating their internationalization strategy, setting up subsidiaries overseas through "acquisition + self-construction" and other methods to increase their international layout and open up the growth ceili.

Challenges still exist International development has become an inevitable trend in the pharmaceutical machine indust.

It is worth mentioning that although the overseas prospects are quite promising, compared with the domestic market, there are still many challenges for local pharmaceutical machine companies to go glob.

For example, China's pharmaceutical machine companies are currently mainly small and medium-sized, and there are generally problems such as low level of equipment informatization and insufficient competitivene.

In addition, local pharmaceutical machine companies may not have enough understanding of local policies, cultures, laws and regulations in the target mark.

situation, it is impossible to enter the road of internationalization and localization very we.

Therefore, domestic pharmaceutical machine companies also need to pay attention to the preliminary research of the target market and conduct better localized layo.

Internally, they should strengthen R&D investment, continuously improve the level of equipment technology, and ensure the quality of equipment is stable, in order to improve the international mark.

Competitiveness makes domestic medicine machines shine in the international mark.

 　　Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyo.